What is Retractable Technologies?
Retractable Technologies operates at the intersection of medical innovation and public health safety. The company specializes in the design, manufacture, and distribution of advanced medical devices, including the VanishPoint and Patient Safe product lines. These technologies are engineered to address two primary healthcare challenges: the prevention of accidental needlestick injuries through automated needle retraction and the reduction of bloodstream infections caused by catheter hub contamination. By providing clinicians with reliable, easy-to-use safety tools, the company has established itself as a vital partner for healthcare facilities aiming to improve patient outcomes and staff safety protocols.
How much funding has Retractable Technologies raised?
Retractable Technologies has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Retractable Technologies
PPP
Public-Private Partnership
What's next for Retractable Technologies?
With the recent influx of capital, Retractable Technologies is poised to accelerate its operational growth and market penetration. The strategic focus will likely center on scaling production to meet the rising demand for safety-engineered medical devices in both domestic and international markets. Furthermore, the company is expected to leverage this financial backing to refine its existing product portfolio, such as the EasyPoint needle system, ensuring compatibility with a broader range of clinical applications. As the healthcare industry continues to prioritize infection control and occupational safety, Retractable Technologies remains a key player in driving the adoption of high-standard medical safety solutions.
See full Retractable Technologies company page
